Stress hyperglycemia in acute ST-segment elevation myocardial infarction is a marker of left ventricular remodeling

Acute Cardiac Care

Volumn 15, Issue 2, 2013, Pages 38-43

  Djordjevic Radojkovic, Danijela ^a   Koracevic, Goran ^a,b   Stanojevic, Dragana ^a   Damjanovic, Miodrag ^a   Apostolovic, Svetlana ^a,b   Pavlovic, Milan ^a,b  

^a CLINICAL CENTER NI   (Serbia)

^b UNIVERSITY OF NI   (Serbia)

Author keywords

Left ventricular remodeling; Mortality; Myocardial infarction

Indexed keywords

ACETYLSALICYLIC ACID; ALTEPLASE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENOXAPARIN; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; STREPTOKINASE;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CARDIAC PATIENT; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; FIBRINOLYTIC THERAPY; GLUCOSE BLOOD LEVEL; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART MUSCLE REPERFUSION; HEART VENTRICLE REMODELING; HIGH RISK PATIENT; HUMAN; HYPERGLYCEMIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STRESS HYPERGLYCEMIA;

AGED; DEATH, SUDDEN, CARDIAC; FEMALE; HOSPITAL MORTALITY; HUMANS; HYPERGLYCEMIA; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROGNOSIS; STRESS, PHYSIOLOGICAL; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 84878792416     PISSN: 17482941     EISSN: 1748295X     Source Type: Journal    
DOI: 10.3109/17482941.2013.781190     Document Type: Article

References (29)

1. Sanjun R, Nez J, Blasco ML, Miana G, Martnez-Maicas H, Carbonell N, et al. Prognostic implications of stress hyperglycemia in acute ST elevation myocardial infarction. Prospective observational study. Rev Esp Cardiol. 2011;64:201-7.
2. Koracevic GP, Petrovic S, Damjanovic M, Stanojlovic T. Association of stress hyperglycemia and atrial fi brillation in myocardial infarction. Wien Klin Wochenschr 2008;120:409-13.
3. Ege M, Gray U, Gray Y, Y lmaz MB, Demirkan B, Sa maz A, et al. Relationship between TIMI frame count and admission glucose values in acute ST elevation myocardial infarction patients who underwent successful primary percutaneous intervention. Anadolu Kardiyol Derg. 2011;11:213-7.
4. Wang CH, Chen YD, Yang XC, Wang LF, Wang HS, Sun ZJ, et al. Th e eff ect of admission hyperglycemia on coronary refl ow in primary percutaneous coronary intervention. Zhonghua Nei Ke Za Zhi 2011;50:303-6.
5. Jensen CJ, Eberle HC, Nassenstein K, Schlosser T, Farazandeh M, Naber CK, et al. Impact of hyperglycemia at admission in patients with acute ST-segment elevation myocardial infarction as assessed by contrast-enhanced MRI. Clin Res Cardiol. 2011 ;100 :649-59.
6. Sanjuan R, Blasco ML, Martinez-Maicas H, Carbonell N, Mi ana G, Nu ez J, et al. Acute myocardial infarction:High risk ventricular tachyarrhythmias and admission glucose level in patients with and without diabetes mellitus. Curr Diabetes Rev. 2011 ;7 :126-34.
7. d e Mulder M, Cornel J H, v an der Ploeg T, Boersma E, Umans V A. Elevated admission glucose is associated with increased long-term mortality in myocardial infarction patients, irrespective of the initially applied reperfusion strategy. Am Heart J. 2010;160:412-9.
8. P arodi G, A ntoniucci D. L eft ventricular remodeling aft er primary percutaneous coronary intervention. Am Heart J. 2010 ;160 :S11-5.
9. Cohn J N, F errari R, Scarpe N. C ardiac remodeling-concepts and clinical implications:A consensus paper from an international forum on cardiac remodeling. J Am Coll Cardiol. 2000 ;35 :569-82. (Pubitemid 30167013)
10. Nicolau JC, Maia LN, Vitola JV, Mahaff ey K W, M achado M N, Ramires JA. Baseline glucose and left ventricular remodeling aft er acute myocardial infarction. J Diabetes Complications 2007 ;21 :294-9. (Pubitemid 47348311)
11. Bauters C, Ennezat PV, Tricot O, Lauwerier B, Lallemant R, Saadouni H, et al. REVE Investigators. Stress hyperglycaemia is an independent predictor of left ventricular remodelling aft er fi rst anterior myocardial infarction in non-diabetic patients. Eur Heart J. 2007 ;28 :546-52. (Pubitemid 47355520)
12. Marfella R, D i Filippo C, P ortoghese M, F erraraccio F, R izzo M R, Siniscalchi M, et al. Tight glycemic control reduces heart infl ammation and remodeling during acute myocardial infarction in hyperglycemic patients. J Am Coll Cardiol. 2009;53:1425-36.
13. Aoki S, Nakagomi A, Asai K, Takano H, Yasutake M, Seino Y, et al. Elevated peripheral blood mononuclear cell count is an independent predictor of left ventricular remodeling in patients with acute myocardial infarction. J Cardiol. 2011;57:202-7.
14. An Y, Yamamuro A, Kaji S, Kinoshita M, Ehara N, Kobori A, et al. Association of admission hyperglycemia with impaired coronary fl ow velocity pattern and left ventricular remodeling in patients with acute anterior myocardial infarction. J Am Coll Cardiol. 2010 ;55 :A189-E1766.
15. D jordjevic Radojkovic D, K oracevic G, Stojanovic D, D amjanovic M, Apostolovic S, Salinger Martinovic S. Stress hyperglycemia is a marker of high risk in acute ST elevation myocardial infarction and marker of left ventricular remodeling. Circulation 2012;125:e671.
16. P apadopoulos C E, K arvounis H I, P arharidis G E. I s stress hyperglycaemia a prognostic marker of left ventricular remodelling aft er fi rst anterior myocardial infarction Eur Heart J. 2007;28:2821. (Pubitemid 350135545)
17. Piestrzeniewicz K, Luczak K, Maciejewski M, Drozdz J. Low adiponectin blood concentration predicts left ventricular remodeling aft er ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention. Cardiol J. 2010 ;17 :49-56.
18. Yoon HJ, Jeong MH, Bae JH, Kim KH, Ahn Y, Cho JG, et al. Dyslipidemia, low left ventricular ejection fraction and high wall motion score index are predictors of progressive left ventricular dilatation aft er acute myocardial infarction. Korean Circ J. 2011;41:124-9.
19. Kosiborod M, Rathore SS, Inzucchi SE, Masoudi FA, Wang Y, Havranek EP, et al. Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction:Implications for patients with and without recognized diabetes. Circulation 2005 ;111 :3078-86. (Pubitemid 40847785)
20. Deedwania P, Kosiborod M, Barrett E, C eriello A, I sley W, Mazzone T, et al. Hyperglycemia and acute coronary syndrome:A scientific statement from the American Heart Association diabetes committee of the council on nutrition, physical activity, and metabolism. Anesthesiology 2008;109:14-24.
21. Mladenovi V, Zdravkovi V, Jovi M, Vuci R, Iri-Cupi V, Rosi M. Infl uence of admission plasma glucose level on shortand long-term prognosis in patients with ST-segment elevation myocardial infarction. Vojnosanit Pregl. 2010 ;67 :291-5.
22. Nicolau JC, Lima FG, Franken M, Serrano CV Jr, Giraldez RR, Baracioli LM, et al. Th e prognostic value of diabetes and of acute hyperglycemia is diff erent during the in-hospital and chronic phases aft er myocardial infarction. J Am Coll Cardiol. 2011 ;57 :E1041.
23. Mather AN, Crean A, Abidin N, Worthy G, Ball SG, Plein S, et al. Relationship of dysglycemia to acute myocardial infarct size and cardiovascular outcome as determined by cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2010;12:61.
24. Vivas D, Garc a-Rubira JC, Bernardo E, Angiolillo DJ, Mart n P, Calle-Pascual A, et al. Infl uence of HbA1c levels on platelet function profi les associated with tight glycemic control in patients presenting with hyperglycemia and an acute coronary syndrome:A subanalysis of the CHIPS Study ( ' Control HI perglucemia y Actividad Plaquetaria en Pacientes con S ndrome Coronario Agudo '). J Th romb Th rombolysis 2013;35:165-74.
25. Pinto DS, Kirtane AJ, Pride YB, Murphy SA, Sabatine MS, Cannon CP, et al.;CLARITY-TIMI 28 Investigators. Association of blood glucose with angiographic and clinical outcomes among patients with ST-segment elevation myocardial infarction (from the CLARITY-TIMI-28 study). Am J Cardiol. 2008;101:303-7. (Pubitemid 351162961)
26. Kadry Z, Danchin N, Vaur L, Cottin Y, Gueret P, Zeller M, et al. Major impact of admission glycaemia on 30 day and one year mortality in non-diabetic patients admitted for myocardial infarction:results from the nationwide French USIC 2000 study. Heart 2006 ;92 :910-5. (Pubitemid 43974051)
27. McGregor AK, Leech N, Purcell IF, Edwards R. Eff ect of primary percutaneous coronary intervention on stress hyperglycaemia in myocardial infarction. Diabet Med. 2012;29:1317-20.
28. D eedwania P, K osiborod M, B arrett E, C eriello A, I sley W, Mazzone T, et al. Hyperglycemia and acute coronary syndrome. A scientifi c statement from the American Heart Association diabetes committee of council on nutrition, physical activity, and metabolism. Circulation 2008;117:1610-9. (Pubitemid 351440650)
29. Verg s B, Avignon A, Bonnet F, Catargi B, Cattan S, Cosson E, et al.;Diabetes and cardiovascular disease study group of the Soci t Francophone du Diab te (SFD), in collaboration with the Soci t Fran aise de Cardiologie (SFC). Consensus statement on the care of the hyperglycaemic/diabetic patient during and in the immediate follow-up of acute coronary syndrome. Diabetes Metab. 2012 ;38 :113-27.